'Worse than ever,' Boston's biotechs stare down traffic crisis — prompting call for more remote working, flex hours
They’d been warned before. Now it might start costing them employees.
The Massachusets Biotechnology Council (MassBio) released their latest commute survey and found “we are in fact at a tipping point:” 60% of respondents would consider changing jobs for an easier commute, a nearly identical number say things are getting worse and it seems just about everyone (90%) who took the MBTA metro became “stressed, angry, or frustrated.”
“In Massachusets, traffic congestion and failures in transportation system are getting worse than ever, and our employees are starting to make decisions around their commute,” MassBio VP of global affairs Elizabeth Steele told Endpoints News. Her commute from within Boston to Kendall Square takes 40 minutes during off-hours.
The report prompted a memo from MassBio chief Robert Coughlin calling for companies to formally allow employees to work from home once-a-week and institute flexible work hours in an effort to curb frustration. The email called the traffic situation a “crisis” at a “breaking point” and called the report’s findings “grim, but not surprising.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 117,800+ biopharma pros reading Endpoints daily — and it's free.